Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Jordan flag Jordan · Delayed Price · Currency is JOD
1.140
0.00 (0.00%)
At close: Oct 8, 2025
Market Cap39.90M
Revenue (ttm)82.70M
Net Income (ttm)4.14M
Shares Out35.00M
EPS (ttm)0.12
PE Ratio9.61
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,625
Average Volume30,513
Open1.140
Previous Close1.140
Day's Range1.130 - 1.140
52-Week Range1.090 - 1.310
Beta0.25
RSI45.28
Earnings DateOct 30, 2025

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatolog... [Read more]

Industry Pharmaceutical Preparations
Founded 1975
Employees 1,111
Stock Exchange Amman Stock Exchange
Ticker Symbol DADI
Full Company Profile

Financial Performance

In 2024, ASE:DADI's revenue was 81.18 million, an increase of 8.42% compared to the previous year's 74.88 million. Earnings were 3.59 million, an increase of 13.41%.

Financial Statements

News

There is no news available yet.